Staar Surgical reported $63.2M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11895M 427M
Atrion ATRI:US 40.29M 2.56M
Boston Scientific BSX:US $ 3026M 101M
Cerus CERS:US $ 43.02M 7.07M
Cooper Companies COO:US $ 829.8M 42.6M
Exact Sciences EXAS:US $ 486.57M 12.76M
Hologic HOLX:US $ 1435.7M 35.4M
Johnson & Johnson JNJ:US $ 23426M 1378M
Meridian Bioscience VIVO:US $ 111.23M 22.89M
Merit Medical Systems MMSI:US $ 275.41M 3.08M
Novartis NOVN:VX SF 12814M 708M
Orasure Technologies OSUR:US $ 67.71M 4.14M
Orthofix International OFIX:US $ 106.42M 18.65M
Sientra SIEN:US $ 21.4M 1.25M
Staar Surgical STAA:US $ 63.2M 4.2M
Utah Medical Products UTMD:US $ 12.57M 1.61M
Valeant Pharmaceuticals VRX:CN $ 1918M 278M